The Ministry of Health has issued a new directive establishing a definitive timeline for the digital transformation of medical records.... Read more
Category: Uncategorized
E-cigarette market shifts to anonymous channels following ban
Research data from the University of Public Health, released on April 9, 2026, reveals a pivotal shift in the management... Read more
Major hospitals boost healthcare quality at Xuan Hoa Ward Medical Center
In an effort to enhance medical expertise and alleviate pressure on tertiary hospitals, Xuan Hoa Ward Medical Center in Ho... Read more
Vietnam suspends new food safety regulations
The Government has issued Resolution 15, officially suspending the implementation of Decree 46 and Resolution 66.13 regarding food safety management.... Read more
GC Biopharma validates proprietary technology to mitigate thromboembolic risks
GC Biopharma has successfully developed and validated a proprietary assay designed to precisely measure impurities linked to thromboembolic risks. This... Read more
Vertex Pharmaceuticals and Halozyme enter exclusive drug delivery partnership
Halozyme Therapeutics Inc. has finalized a global exclusive collaboration and licensing agreement with Vertex Pharmaceuticals Incorporated. Under this pact, Vertex... Read more
AC Immune and Eli Lilly amend partnership to develop Alzheimer’s therapies
AC Immune SA and Eli Lilly and Company have officially amended their 2018 licensing and collaboration agreement to advance the... Read more
Biocon launches two Denosumab biosimilars, Aukelso and Bosaya, in the U.S. market
Pharmaceutical giant Biocon has officially commenced the commercial launch of two biosimilars, Aukelso and Bosaya, in the United States. These... Read more
Amgen reports success in Phase 3 trial of subcutaneous Tepezza
Amgen has announced that a subcutaneous version of its blockbuster drug Tepezza—a treatment for thyroid eye disease (TED)—successfully met both... Read more









